BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 8608237)

  • 1. CD5-CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas.
    Emile JF; Boulland ML; Haioun C; Kanavaros P; Petrella T; Delfau-Larue MH; Bensussan A; Farcet JP; Gaulard P
    Blood; 1996 Feb; 87(4):1466-73. PubMed ID: 8608237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasal and nasal-type T/NK-cell lymphoma with cutaneous involvement.
    Kato N; Yasukawa K; Onozuka T; Kikuta H
    J Am Acad Dermatol; 1999 May; 40(5 Pt 2):850-6. PubMed ID: 10321634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in T-cell-receptor gene rearrangement and transcription in nasal lymphomas of natural killer and T-cell types: implications on cellular origin.
    Chiang AK; Srivastava G; Lau PW; Ho FC
    Hum Pathol; 1996 Jul; 27(7):701-7. PubMed ID: 8698315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus.
    Kanavaros P; Lescs MC; Brière J; Divine M; Galateau F; Joab I; Bosq J; Farcet JP; Reyes F; Gaulard P
    Blood; 1993 May; 81(10):2688-95. PubMed ID: 8387835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of cyclin-dependent kinase 6 (cdk6) and frequent loss of CD44 in nasal-nasopharyngeal NK/T-cell lymphomas: comparison with CD56-negative peripheral T-cell lymphomas.
    Lien HC; Lin CW; Huang PH; Chang ML; Hsu SM
    Lab Invest; 2000 Jun; 80(6):893-900. PubMed ID: 10879740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin.
    Cooke CB; Krenacs L; Stetler-Stevenson M; Greiner TC; Raffeld M; Kingma DW; Abruzzo L; Frantz C; Kaviani M; Jaffe ES
    Blood; 1996 Dec; 88(11):4265-74. PubMed ID: 8943863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm.
    Chan JK; Sin VC; Wong KF; Ng CS; Tsang WY; Chan CH; Cheung MM; Lau WH
    Blood; 1997 Jun; 89(12):4501-13. PubMed ID: 9192774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nasal T/natural killer (NK)-cell lymphomas are derived from Epstein-Barr virus-infected cytotoxic lymphocytes of both NK- and T-cell lineage.
    Chiang AK; Chan AC; Srivastava G; Ho FC
    Int J Cancer; 1997 Nov; 73(3):332-8. PubMed ID: 9359478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Most CD56+ intestinal lymphomas are CD8+CD5-T-cell lymphomas of monomorphic small to medium size histology.
    Chott A; Haedicke W; Mosberger I; Födinger M; Winkler K; Mannhalter C; Müller-Hermelink HK
    Am J Pathol; 1998 Nov; 153(5):1483-90. PubMed ID: 9811340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic and genotypic study of extranodal nasal-type natural killer/T-cell lymphoma and natural killer precursor lymphoma among Koreans.
    Ko YH; Ree HJ; Kim WS; Choi WH; Moon WS; Kim SW
    Cancer; 2000 Nov; 89(10):2106-16. PubMed ID: 11066052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of cytotoxic proteins in peripheral T-cell and natural killer-cell (NK) lymphomas: association with extranodal site, NK or Tgammadelta phenotype, anaplastic morphology and CD30 expression.
    Kanavaros P; Boulland ML; Petit B; Arnulf B; Gaulard P
    Leuk Lymphoma; 2000 Jul; 38(3-4):317-26. PubMed ID: 10830738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blastic natural killer cell and extranodal natural killer cell-like T-cell lymphoma presenting in the skin: report of six cases from the UK.
    Child FJ; Mitchell TJ; Whittaker SJ; Calonje E; Spittle M; Crocker J; Russell-Jones R
    Br J Dermatol; 2003 Mar; 148(3):507-15. PubMed ID: 12653743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of killer cell inhibitory receptors is restricted to true NK cell lymphomas and a subset of intestinal enteropathy-type T cell lymphomas with a cytotoxic phenotype.
    Dukers DF; Vermeer MH; Jaspars LH; Sander CA; Flaig MJ; Vos W; Willemze R; Meijer CJ
    J Clin Pathol; 2001 Mar; 54(3):224-8. PubMed ID: 11253136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.
    Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H
    Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of adult and fetal natural killer cell markers in sinonasal lymphomas.
    Suzumiya J; Takeshita M; Kimura N; Kikuchi M; Uchida T; Hisano S; Eura Y; Kozuru M; Nomura Y; Tomita K
    Blood; 1994 Apr; 83(8):2255-60. PubMed ID: 8161791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD3- CD56+ non-Hodgkin's lymphomas with an aggressive behavior related to multidrug resistance.
    Drénou B; Lamy T; Amiot L; Fardel O; Caulet-Maugendre S; Sasportes M; Diebold J; Le Prisé PY; Fauchet R
    Blood; 1997 Apr; 89(8):2966-74. PubMed ID: 9108417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, immunohistochemical and phenotypic features of aggressive nodal cytotoxic lymphomas, including alpha/beta, gamma/delta T-cell and natural killer cell types.
    Ohshima K; Suzumiya J; Sugihara M; Kanda M; Shimazaki K; Kawasaki C; Haraoka S; Kikuchi M
    Virchows Arch; 1999 Aug; 435(2):92-100. PubMed ID: 10599306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nodal T/NK-cell lymphoma of nasal type: a clinicopathological study of six cases.
    Takahashi E; Asano N; Li C; Tanaka T; Shimada K; Shimada S; Yoshino T; Kojima M; Hara K; Eimoto T; Nakamura S
    Histopathology; 2008 Apr; 52(5):585-96. PubMed ID: 18370955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classification of cell lineage and anatomical site, and prognosis of extranodal T-cell lymphoma -- natural killer cell, cytotoxic T lymphocyte, and non-NK/CTL types.
    Ohshima K; Liu Q; Koga T; Suzumiya J; Kikuchi M
    Virchows Arch; 2002 Apr; 440(4):425-35. PubMed ID: 11956825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic protein expression in natural killer cell lymphomas and in alpha beta and gamma delta peripheral T-cell lymphomas.
    Boulland ML; Kanavaros P; Wechsler J; Casiraghi O; Gaulard P
    J Pathol; 1997 Dec; 183(4):432-9. PubMed ID: 9496260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.